Today's pre-market stock movers: PTON, PEP, NVAX, GPS and more

• $Canoo(GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)

• $Aldeyra Therapeutics(ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)

• $Westport Fuel(WPRT.US)$ +10.9% (awarded 38 mln program)

• $Greenwich LifeSciences(GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed; suspends share repurchase program)

• $BELLUS Health(BLU.US)$ +5.4% (reports End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough)

• $Cohu Inc(COHU.US)$ +3.5% (Cohu (COHU) said Monday it expects Q2 revenue of $216 million to $218 million, higher than the guidance range mid-point of $213 million)

• $Leap Therapeutics(LPTX.US)$ +3.2% (Leap Therapeutics and BeiGene (BGNE) announce the initiation of Part C of the ongoing DisTinGuish study to evaluate DKN-01 Leap's anti-SSEDickkopf 1 (DKK1) antibody in combination with tislelizumab BeiGene's anti-PD-1 antibody)

• $Clarivate(CLVT.US)$ +3% (CEO to retire; names new CEO)

• $Dave & Buster's Entertainment(PLAY.US)$ +2.3% (names new execs following Main Event acquisition names new COO; entered into an amendment and restatement of the cooperation letter agreement with Hill Path Capital and James Chambers)

• $Aerojet Rocketdyne(AJRD.US)$ +2.3% (names new chairman)

• $Glaukos(GKOS.US)$ +2.1% (upgraded to Buy from Hold at Stifel)

• $Fulcrum Therapeutics(FULC.US)$ -12.1% (CMO to step down)

• $VOXX International(VOXX.US)$ -11%,

• $RxSight(RXST.US)$ -6.7% (received notification from the FDA that additional information will be required for the approval of its lower- cost-to-manufacture Light Delivery Device)

• $Pliant Therapeutics(PLRX.US)$ -6.2% (stock offering)

• $Fluor(FLR.US)$ -4.1% (awarded a new contract by New Fortress Energy)

• $Brookdale Senior Living(BKD.US)$ -2% (reports June operating metrics)

• $Capital One Financial(COF.US)$ -2.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley; downgraded to Perform from Outperform at Oppenheimer)

• $C.H. Robinson Worldwide(CHRW.US)$ -1.5% (downgraded to Peer Perform from Outperform at Wolfe Research)